These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1295715

  • 1. The long-term effects of recombinant human erythropoietin on the cardiovascular system.
    Eschbach JW, Aquiling T, Haley NR, Fan MH, Blagg CR.
    Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715
    [Abstract] [Full Text] [Related]

  • 2. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M.
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M, Umezu M, Nagano M, Tagawa H.
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [Abstract] [Full Text] [Related]

  • 5. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [Abstract] [Full Text] [Related]

  • 6. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL, Zezina LIu, Spudass AV.
    Ter Arkh; 1991 Mar; 63(12):110-3. PubMed ID: 1803587
    [Abstract] [Full Text] [Related]

  • 9. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS, Rudnick MR, Cohen RM.
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [Abstract] [Full Text] [Related]

  • 10. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M, Teixeira de Sousa F, Barbas J, Vinhaś J, Marques da Costa A.
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [Abstract] [Full Text] [Related]

  • 11. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S, al-Momen AK, Gader AM, Mitwalli A, Sulimani F, Abu-Aisha H.
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C, Berthelot JM, Chiappini-Judith D, Ferragu-Haguet M, Lefebvre A, Masselot JP, Moynot A, Frydman MO, Peterlongo F.
    Nephrologie; 1990 Nov; 11(1):11-6. PubMed ID: 2374641
    [Abstract] [Full Text] [Related]

  • 13. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [Abstract] [Full Text] [Related]

  • 14. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW, Adamson JW.
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [Abstract] [Full Text] [Related]

  • 15. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R, Steffen HM, Brunner R, Saric J, Pollok M, Baldamus CA, Kaufmann W.
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
    Muirhead N, Laupacis A, Wong C.
    Nephrol Dial Transplant; 1992 Mar; 7(8):811-6. PubMed ID: 1325613
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Mar; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 20. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
    Boratyńska M, Szewczyk Z, Szepietowski T, Czyz W, Cybulski K, Bogucki J, Szczepański J.
    Przegl Lek; 1990 Mar; 47(11):741-5. PubMed ID: 2098840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.